0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Articles |

The Influence of HLA-DRB1 Genes on Disease Severity in Rheumatoid Arthritis

Cornelia M. Weyand, MD, PhD; Kevin C. Hicok, MS; Doyt L. Conn, MD; and Jörg J. Goronzy, MD, PhD
[+] Article and Author Information

Grant Support: In part by a grant from the Arthritis Prostaglandins Research Challenge and by the Mayo Foundation. Dr. Weyand is the recipient of an Arthritis Foundation investigator award.

Requests for Reprints: Cornelia M. Weyand, MD, PhD, Mayo Clinic, 401 Guggenheim, 200 First Street SW, Rochester, MN 55905.

Current Author Addresses: Drs. Weyand, Conn, and Goronzy and Mr. Hicok: Mayo Clinic, 200 First Street, SW, Rochester, MN 55905.


© 1992 American College of PhysiciansAmerican College of Physicians


Ann Intern Med. 1992;117(10):801-806. doi:10.7326/0003-4819-117-10-801
Text Size: A A A

Objective: To explore the role of HLA-DRB1 genes in determining disease severity in rheumatoid arthritis.

Design: Case series of patients with seropositive rheumatoid arthritis.

Setting: The outpatient clinic of the Division of Rheumatology, Mayo Clinic.

Patients: One hundred and two patients with seropositive, erosive rheumatoid arthritis and a minimum disease duration of 3 years.

Measurements: Patients were genotyped for both HLA-DRB1 alleles and were categorized according to the expression of one or two disease-linked HLA-DRB1 alleles. Identification of HLA-DRB1 alleles was done by the polymerase chain reaction and subsequent oligonucleotide hybridization. Homozygosity for allelic variants was confirmed by sequence analysis. Immunogenetically defined patient subgroups were retrospectively evaluated for joint destruction and patterns of disease manifestation, including rheumatoid organ disease.

Results: Of 102 patients, 98 (96%) expressed the disease-linked sequence polymorphism. Forty-seven patients (46%) carried a double dose of the relevant sequence stretch: Twenty-eight patients expressed HLA-DRB1*04 variants on both alleles, and 19 combined an HLA-DRB*04 variant with HLA-DRB1*0101 or DRB1*1402. Nodular disease was present in 100% of patients typed as HLA-DRB1*04/04 and in 59% of patients typed as HLA-DRB1*04 and who had inherited only a single dose of the disease-linked sequence polymorphism (P < 0.0001). Major organ systems were involved in 61% and 11% of these two patient groups, respectively (P < 0.0001); and joint surgery was required in 61% and 25% (P < 0.002), respectively. Patients typed as HLA-DR*04/01 had intermediate clinical courses.

Conclusion: Genotyping patients with rheumatoid arthritis for both HLA-DRB1 alleles identifies clinical subsets with distinct profiles of disease manifestations.

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections
PubMed Articles

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)